A Collaborative Approach to Advancing Access and Equity in Rare Disease Clinical Trials

Terence Eagleton, MB BS, BSc, Senior Medical Director, Medpace

Dr. Terence Eagleton is a UK-based physician who qualified from University College London Medical School, after which he trained as a general surgeon with a focus on trauma and critical patient care. He has subsequently worked as a senior pharmaceutical physician in the biopharma and CRO industries for over 20 years in global clinical research and medical affairs, in a wide variety of therapeutic areas. He has extensive experience and achievement in international orphan drug development across Phase I to IV, with a specific focus in clinical research with a variety of innovative therapeutic modalities. Dr. Eagleton is an affiliate member of the Faculty of Pharmaceutical Medicine (FPM) in the UK. He has authored original papers in peer-reviewed journals and established himself as an industry expert in rare diseases.

Miaesha Campbell, Senior Director, Patient Recruitment, Medpace

Miaesha Campbell is an accomplished professional with over 15 years of experience directing a global team of strategic partners, support staff and vendors for multimillion-dollar global marketing, patient recruitment and patient retention campaigns. This includes oversight of the planning and execution of programs with budgets ranging from $250,000 to $17 million. Miaesha graduated from California State University at Dominquez Hills in May 2002, earning a Bachelor of Arts degree in English and a Minor in Communications. Her early career was spent in public relations, and she was recruited to support the marketing of clinical trial programs in 2007.

Kristin Black, Clinical Trial Manager, Medpace

Ms. Black started her career at Medpace in 2015 as a CRA, where she sharpened her strong leadership skills propelling her into the role of CTM. Kristin has significant experience working as a lead CRA and CTM in LSDs, cardiology, metabolic disorders, neurology, and rare disease trials. Kristin’s training and experience in rare disease, and proven track record of success building relationships, make her a natural fit as CTM.

Nita Patel, RN, Executive Director, Patient Advocacy at Amicus Therapeutics

Nita is a registered nurse with experience in clinical research, obstetrics and genetic nursing. She has been working at Amicus since September 2011. Her expertise in lysosomal diseases was gained from managing a lysosomal treatment center for approximately 15 years at St. Peter’s University Hospital Institute for Genetic Medicine located in New Brunswick, NJ. Nita has also provided training and education for patients in renal failure receiving peritoneal dialysis, pre-natal teratology counseling and testing. Nita has also monitored clinical studies in lysosomal disorders; her passion is to advocate for patients and represent their voice to industry and drug development. Nita has been an Ambassador for Needy Meds; she continues to help patients with their needs to access the medical care they deserve. Since 2016, Nita has been a faculty member for Professional Patient Advocates in the Life Sciences (PPALS), she lectures on Patient Advocacy and “Return on Investment”.

Nita has completed midwifery training in London, UK; received Genetic Nurse Certification, Obstetric Nurse certification and Clinical Research certification.